Effect of nifedipine on renal function in liver transplant recipients receiving tacrolimus

Clinical Therapeutics

Volumn 18, Issue 3, 1996, Pages 491-496

  Seifeldin, Raafat ^a   Marcos Alvarez, Amadeo ^b,c   Lewis, W David ^b,c   Gordon, Fredric D ^b,c   Jenkins, Roger L ^b,c  

^a NORTHEASTERN UNIVERSITY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; NIFEDIPINE; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT REJECTION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; RETROSPECTIVE STUDY;

EID: 0029973430     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80030-0     Document Type: Article

References (16)

1. Textor SC, Burnett JC Jr, Romero JC, et al. Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. Kidney Int. 1995; 47:1426-1433.
2. Ruilope LM, Lahera V, Rodicio JL. Evaluation of the renal effects of calcium antagonists. J Cardiovasc Pharmacol. 1994; 23(Suppl 5):S49-S53.
3. Reams GP. Calcium channel blockers: Do they offer renal protection? J Hum Hypertens. 1993;7:211-219.
4. Loutzenhiser R, Epstein M. Effects of calcium antagonists on renal hemodynamics. Am J Physiol. 1985;249(5 Pt 2):F619-F629.
5. Fleming JT, Parekh N, Steinhausen M. Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney. Am J Physiol. 1987;253(6 Pt 2): F1157-F1163.
6. Carmines PK, Navar LG. Disparate effects of Ca channel blockade on afferent and efferent arteriolar response to ANG II. Am J Physiol. 1990;259(6 Pt 2):F598-F604.
7. Dworkin LD, Levin RI, Benstein JA, et al. Effects of nifedipine and enalapril on glomerular injury in rats with deoxycorticosterone-salt hypertension. Am J Physiol. 1990;259(4 Pt 2):F598-F604.
8. Sunderrajan S, Reams GP, Bauer JH. Renal effects of diltiazem in primary hypertension. Hypertension. 1986;8:238-242.
9. Kubo SH, Cody RJ, Covit AB, et al. The effects of verapamil on renal blood flow, renal function, and neurohormonal profiles in patients with moderate to severe hypertension. J Clin Hypertens. 1986;32 (Suppl 3):38S-46S.
10. Pedersen B, Anderson OK, Wysocki M, et al. Renal and hemodynamic effects of isradipine in essential hypertension. Am J Med. 1989;86:(Supp 14A):60-64.
11. Reams GP, Hamory A, Lau A, et al. Effect of nifedipine on renal function in patients with essential hypertension. Hypertension. 1988;11:452-456.
12. Thananopavann C, Golub MS, Eggena P, et al. Renal effects of nitrendipine monotherapy in essential hypertension. J Cardiovasc Pharmacol. 1984;6(Suppl 7):S1032-S1036.
13. Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ. 1991; 302:210-216.
14. Klintmalm GB. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. NEJM. 1994;331:1110-1115.
15. Williams R. Randomized trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet. 1994;334:423-428.
16. Neumayer HH, Gellert J, Luft FC. Calcium antagonists and renal protection. Renal Fail. 1993;15:353-358.